
|Articles|September 23, 2009
StudyManager Expands into China
Advertisement
“China is the next logical step for us,” said Bruce Schatzman, Founder and Chief Executive Officer of StudyManager. “Because the cost of paper trials in China is still very competitive, we believe our EDC solution is a great choice when Chinese CROs and sponsors don’t see the price/performance value offered by larger EDC providers.”
To accomadate Asian expansion, StudyManager opened a data center in Shanghai, from which Chinese companies can run its EDC/CTMS system in what it calls "a secure and compliant manner."
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
A Shot in the Arm to Traditional Vaccine Trial Strategy
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
SCOPE X: What Real-Time Patient Data Is Doing to ClinOps Efficiency
5




